FTC says it wants more information about $43B Pfizer-Seagen deal
The Federal Trade Commission wants more information on Pfizer’s takeover of Seagen before it will make a ruling on whether it will clear the $43 billion deal.
The FTC’s action, known as a second request for information, may stretch the time it takes for the deal to close, though Seagen said in a securities filing on Friday the companies expect the deal to close at the end of this year or the first part of 2024. Pfizer has sent signals that it expected such a request from antitrust regulators, though the drugmaker has also said it hasn’t seen signs that the FTC will ultimately try to block the acquisition.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
